Skip to main content
Ortivus logo

Ortivus — Investor Relations & Filings

Ticker · ORTI ISIN · SE0000188930 LEI · 549300AVDV7UC14MTH79 ST Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2024-06-05 Capital/Financing Update
Country SE Sweden
Listing ST ORTI

About Ortivus

https://www.ortivus.com/

Ortivus is a medical technology company that develops and supplies mobile solutions for prehospital and emergency medical care. The company's core product is MobiMed, an advanced electronic Patient Care Record (ePCR) system designed for paramedics and emergency medical services (EMS) providers. MobiMed facilitates real-time documentation and data sharing directly from the field. The platform integrates with a wide range of medical devices, such as patient monitors and defibrillators, as well as with hospital patient administration systems and national health registries. This ensures seamless information flow across the entire care pathway. Key functionalities include structured workflows, automated risk assessments, secure communication, and a web portal for real-time incident overviews. The system also supports telemedicine capabilities, including video consultations. By optimizing documentation and providing actionable insights, Ortivus solutions aim to improve patient safety, enhance care quality, and increase operational efficiency for healthcare organizations.

Recent filings

Filing Released Lang Actions
Ortivus has secured a 10 MSEK credit line agreement with its principal owner
Capital/Financing Update Classification · 98% confidence The document announces a specific corporate action: securing a 10 MSEK credit line agreement with a principal owner to strengthen liquidity following a cyber-attack. This is a material event disclosure. It is not a full Annual Report (10-K), an Interim Report (IR), an Earnings Release (ER), or a Dividend Notice (DIV). It relates to financing and capital structure changes, specifically securing debt/credit. This aligns best with the 'Capital/Financing Update' category (CAP). Although it is a short announcement, the content is the primary disclosure itself (the agreement details), not just an announcement *about* a report, which would trigger RPA/RNS. The final sentence mentions the information is submitted pursuant to the EU Market Abuse Regulation, typical for such material disclosures.
2024-06-05 English
Joanna Daffy Tiitus resigns as Marketing and Communications Manager at Ortivus
Board/Management Information Classification · 98% confidence The document is a short announcement detailing the resignation of a senior manager, Joanna Daffy Tiitus, from her role as Marketing and Communications Manager. It includes quotes from the CEO and contact information. The final paragraph mentions that the information is made public pursuant to the EU Market Abuse Regulation and includes an attachment link. This type of announcement, concerning changes in senior management, directly corresponds to the definition of 'Board/Management Information' (MANG). It is not a full financial report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), as it pertains to a specific management change.
2024-06-03 English
Joanna Daffy Tiitus avgår som Marknads- och Kommunikationschef på Ortivus
Board/Management Information Classification · 100% confidence The document is a short announcement (3077 characters) stating that the Chief Marketing and Communications Officer, Joanna Daffy Tiitus, is leaving the company (Ortivus) and provides her last working day. It includes contact information and a brief 'About Us' section. Crucially, the final line states: "Denna information är sådan information som Ortivus är skyldigt att offentliggöra enligt EU:s marknads­missbruksförordning" (This information is such information that Ortivus is obliged to make public according to the EU Market Abuse Regulation). This strongly suggests a mandatory regulatory disclosure. Since the content is specifically about a change in senior management (Marknads- och Kommunikationschef/member of the management group), the most appropriate classification is Board/Management Information (MANG). It is not a full financial report (10-K, IR) or a general regulatory filing (RNS), as MANG is more specific for management changes.
2024-06-03 Swedish
Ortivus tilldelas kontrakt avseende leverans av MobiMed enRoute till Region Örebro
Regulatory Filings Classification · 100% confidence The document announces that Ortivus has been awarded a contract by Region Örebro län for the delivery of MobiMed enRoute, valued at 8.3 MSEK over 5 years. It details the scope of the contract (software licenses, hardware, integration, training) and includes a quote from management. Crucially, the final line states: "Denna information är sådan information som Ortivus är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning" (This information is such information that Ortivus is obliged to disclose pursuant to the EU's Market Abuse Regulation). This strongly indicates a mandatory regulatory disclosure regarding a significant business event (a major contract award). Since it is an announcement of a significant event rather than a periodic financial report (10-K, IR) or a general transcript (CT), it fits best under the general regulatory announcement category, RNS, as it is a disclosure mandated by market rules (MAR). It is not a Director's Dealing (DIRS), a Dividend Notice (DIV), or a Capital Change (CAP).
2024-05-20 Swedish
Ortivus is awarded a contract for the delivery of MobiMed enRoute to Region Örebro
Regulatory Filings Classification · 100% confidence The document announces a specific business event: Ortivus being awarded a contract by Region Örebro län for the delivery of MobiMed enRoute. It details the contract value (8.3 MSEK) and duration (5 years). The text concludes with a statement: "This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication...". This structure strongly suggests a mandatory regulatory disclosure regarding a significant business transaction or contract award. Since it is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA), and it pertains to a specific business development that must be made public under EU regulations, it fits best under the general 'Regulatory Filings' category (RNS) as a miscellaneous, mandatory announcement that doesn't fit the other specific codes like M&A (TAR) or Capital Change (CAP). The document length is short (4130 chars) and it announces information rather than being the full report itself, but RNS is the most appropriate catch-all for mandatory, non-financial-statement regulatory news.
2024-05-20 English
The contract for the delivery of MobiMed to Region Norrbotten has now been signed
Regulatory Filings Classification · 95% confidence The document is a press release announcing the signing of a commercial contract between Ortivus and Region Norrbotten. It details the contract value, duration, and scope of services. Since it does not fit into specific categories like M&A (which usually refers to corporate mergers/acquisitions), financial reporting, or governance, and is a general corporate announcement regarding business operations, it falls under the 'Regulatory Filings' (RNS) category as a catch-all for miscellaneous corporate announcements.
2024-05-20 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.